TITLE

Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia

AUTHOR(S)
Brancati, F.; Valente, E.M.; Castori, M.; Vanacore, N.; Sessa, M.; Galardi, G.; Berardelli, A.; Bentivoglio, A.R.; Defazio, G.; Girlanda, P.; Abbruzzese, G.; Albanese, A.; Dallapiccola, B.; Italian Movement Disorder Study Group
PUB. DATE
May 2003
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;May2003, Vol. 74 Issue 5, p665
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Cervical dystonia (CD) is one of the most common forms of primary dystonia. The pathogenesis of the disease is still unknown, although evidence suggests a role for genetic factors. Recently, a polymorphism in the dopamine D5 receptor (DRD5) gene has been associated with the disease in a British population, suggesting that DRD5 is a susceptibility gene for CD. To confirm these data, we performed a case-control study of the microsatellite (CT/GT/GA)(n) at the DRD5 locus in 104 Italian CD patients and 104 healthy controls. The frequency of allele 4 was higher in the CD patients compared to the controls. This resulted in a twofold increased risk of developing the disease. These results provide further evidence of an association between DRD5 and cervical dystonia, supporting the involvement of the dopamine pathway in the pathogenesis of CD.
ACCESSION #
10077769

 

Related Articles

  • Recent developments in Parkinson’s disease. Strupp, Michael // Journal of Neurology;Feb2005, Vol. 252 Issue 2, p245 

    The article presents information on some recent developments in Parkinson's disease. Some of the developments are: Levodopa and the progression of Parkinson's disease; Levodopa-induced changes in synaptic dopamine levels increase with progression of PD: implications for dyskinesias; Electron...

  • Butamirate.  // Reactions Weekly;3/16/2013, Issue 1444, p13 

    The atricle presents the case of a 4-year-old girl, who developed acute cervical dystonia while getting treatment with butamirate for upper airway infection.

  • Striatal dopaminergic system in dopa-responsive dystonia: a multi-tracer PET study shows increased D2 receptors. Rinne, J. O.; Iivanainen, M.; Metsähonkala, L.; Vainionpää, L.; Pääkkönen, L.; Någren, K.; Helenius, H. // Journal of Neural Transmission;Jan2004, Vol. 111 Issue 1, p59 

    Summary. We investigated the integrity of striatal dopaminergic system in seven patients with dopa-responsive dystonia (DRD). Dopamine transporter function ([11C]CFT) and D1 ([11C]NNC 756) and D2 receptors ([11C]raclopride) were studied in same patients using positron emission tomography....

  • Tardive Oculogyric Crisis during Treatment with Clozapine: Report of Three Cases. Uzun, Özcan; Doruk, Ali // Clinical Drug Investigation;2007, Vol. 27 Issue 12, p861 

    Tardive oculogyric crisis (OGC) is a dystonic syndrome that starts after long-term use of dopamine receptor antagonists. Atypical antipsychotics have reduced liability for inducing tardive dystonia and show antidystonic properties in patients with pre-existing tardive dystonia. Clozapine is an...

  • Normal dopamine transporter binding in dopa responsive dystonia. Chin-Chang Huang; Tzu-Chen Yen; Yi-Hsin Weng; Chin-Song Lu // Journal of Neurology;Aug2002, Vol. 249 Issue 8, p1016 

    We report the clinical manifestations of dopa responsive dystonia (DRD) in 2 patients from the same family. The brain magnetic resonance images (MRI) were normal. The dopamine transporter (DAT) imaging with 99mTc-TRODAT-1 was performed in the 2 probands, 8 patients with young onset Parkinson...

  • New Perspectives on Dystonia. Langlois, M�lanie; Richer, Francois; Chouinard, Sylvain // Canadian Journal of Neurological Sciences;Mar2003, Vol. 30, pS34 

    Examines the varied phenomenology of dystonias. Evolving classification; Genetic data; Clinical investigation and treatment.

  • TREATMENT OF THE INTERARYTENOID MUSCLE WITH BOTULINUM TOXIN FOR LARYNGEAL DYSTONIA. Hille, Allen D.; Maronian, Nicole C.; Robinson, Lawrence; Waugh, Patricia F.; Klotz, Darrell A. // Annals of Otology, Rhinology & Laryngology;May2004 Part 1 of 2, Vol. 113 Issue 5, p341 

    The treatment of laryngeal dystonia with botulinum toxin has provided various degrees of relief to the majority of patients with adductor dysphonia; however, a significant number of patients have limited or no improvement with this type of therapy. It remains unclear why some patients respond to...

  • Metoclopramide: Pharmacology and Clinical Application. Albibi, Riyad; McCallum, Richard W. // Annals of Internal Medicine;Jan1983, Vol. 98 Issue 1, p86 

    Provides information on a study which reviewed the indications for which the application of dopamine antagonist metoclopramide is approved in the U.S. Function of metoclopramide; Result of metoclopramide's effect on the medullary chemoreceptor trigger zone; Abilities of metoclopramide related...

  • Rivastigmine-induced dystonia. Pavlis, Clay J.; Kutscher, Eric C.; Carnahan, Ryan M.; Kennedy, W. Klugh; Van Gerpen, Shawn; Schlenker, Evelyn // American Journal of Health-System Pharmacy;12/1/2007, Vol. 64 Issue 23, p2468 

    Purpose. A case of acute dystonia related to rivastigmine use is reported. Summary. A 61-year-old Caucasian woman who had suffered from bipolar II disorder with rapid cycling for over 30 years was admitted to an inpatient psychiatry unit. In addition to bipolar II disorder, the patient had been...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics